PHSYX Mutual Fund

NAV$68.87

Fund Essentials - as of Dec 31, 2025

Net Assets
-
Expense Ratio
0.79%
Dividend Yield (Current)
0.36%
Holdings
43
Inception Date
Apr 4, 2000
Fund Family
Putnam Investments
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+4.01%
1 Year+10.55%
3 Year+10.38%
5 Year+8.10%
10 Year+9.95%

Asset Allocation

Stocks: 98.92%
Bonds: 0.12%
Cash: 0.94%
Other: 0.02%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co12.50%
JNJJohnson & Johnson7.97%
ABBVAbbvie Inc7.03%
UNHUnitedHealth Group Incorporated5.25%
AZN:LNAstrazeneca Plc5.25%
Top 10 Concentration: 58.38%Report Date: Dec 31, 2025
Download all 43 holdings for PHSYX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.36%
Frequency
Annually

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

PHSYX Mutual Fund Overview

PHSYX Mutual Fund (Putnam Global Health Care Fund Class Y) is managed by Putnam Investments. PHSYX expense ratio is 0.79%, holding 43 positions across sectors including Health Care, Unknown, Other. Inception date: 2000-04-04.

PHSYX performance shows a YTD return of 4.01%. The 1-year return is 10.55% and the 5-year return is 8.10%. PHSYX dividend yield stands at 0.36%, paid annually.

PHSYX top holdings include Eli Lilly & Co (12.5%), Johnson & Johnson (8.0%), Abbvie Inc (7.0%), UnitedHealth Group Incorporated (5.3%), Astrazeneca Plc (5.3%). View all PHSYX holdings, sector breakdown, or dividend history.

PHSYX can be compared against other funds using the overlap calculator or side-by-side comparison tool. PHSYX alternatives are available via the screener, along with tax-loss harvesting opportunities.